Cardiology Letters 2016, 25(4):286-292
The impact of the use of extracorporeal circulation on the early postoperative IgG concentrations: potential effect on the outcome in cardiac surgery patients - pilot study
- 1 Klinika kardiochirurgie, NÚSCH a. s., Bratislava, Slovenská republika
- 2 Univerzita Pavla Jozefa Šafárika, Lekárska Fakulta, Klinika srdcovej chirurgie, VÚSCH a. s., Košice, Slovenská republika
- 3 Univerzita Pavla Jozefa Šafárika, Lekárska Fakulta, Ústav lekárskej a klinickej biochémie, Košice, Slovenská republika
- 4 Cyperská univerzita, Katedra chémie, Nikózia, Cyprus
Objective: This study tried to elucidate the role of the cardiopulmonary bypass on the early postoperative immunoglobulin G levels and any probable effects on the postoperative outcome of the patients.
Methods: A heterogeneous group for clinical study consisted of 117 consecutive patients. The evening after surgery the level of the IgG was obtained. The postoperative course of each patient during the first three days was followed. One way ANOVA was used for statistical analysis.
Results: Twenty patients (17.09%) had decreased early postoperative immunoglobulin G levels. One hundred and five patients (89.74%) were operated on with cardiopulmonary bypass and 17 (16.19%) of them had lower levels of postoperative immunoglobulin G. The statistical analysis between the two groups included: pulmonary infiltrations, leukocytosis >15x103/mm3, pulmonary dysfunction, mechanical ventilation >24h, renal and hepatic dysfunction, postoperative ileus, postoperative delirium, sternal wound infection, thrombocytopenia < 60x103/mm3 and sepsis. The statistical results were: p=0.8145, p=0.8844, p=0.9360, p=0.3032, p=0.6766, p=0.1394, p=0.8403, p=0.3890, p=0.7658, respectively.
Conclusion: In this clinical study we tried to explore the role of cardiopulmonary bypass on the early postoperative levels of IgG and to establish any correlation with the postoperative outcome. The use of CPB and its duration did not prove to be risk factors for low early postoperative IgG levels. From all of the cardiac surgery patients who were operated on electively or urgently, 16.19% of them who were operated on with cardiopulmonary bypass had low early postoperative IgG levels, without any significant increased clinicallyadverse events. In our opinion the prophylactic use of intravenous immunoglobulins in this group of patients has no benefit.
Keywords: postoperative complications; immunoglobulin G; cardiopulmonary bypass; cardiac surgery
Published: April 1, 2016 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Rankin JS, Glower DD, Teichmann TL, Muhlbaier LH, Stratton CW. Immunotherapy for refractory pulmonary infection after adult cardiac surgery: immune dysregulation syndrome. J Heart Valve Dis 2005;14:783-791.
- Lante W, Franke A, Weinhold C, Markewitz A. Immunoglobulin levels and lymphocyte subsets following cardiac operations: further evidence for a T-helper cell shifting. J Thorac Cardiovasc Surg 2005;53(1):16-22.
Go to original source... - Siminelakis S, Bossinakou I, Antoniou F, Pallanza Z, Tolios J, Vasilogiannakopoulou D, Kasapli M, Parigori P, Chlapoutakis E. A study of the effects of extracorporeal circulation on the immunologic system of humans. J Cardiovasc Vasc Anesth 1996;7:893-898.
Go to original source... - Szerafin T, Niederpold T, Mangold A, Hoetzenecker K, Hacker S, Roth G, Lichtenauer M, Dworschak M, Wolner E, Ankersmit HJ. Secretion of soluble ST2: possible explanation for systemic immunosuppression after cardiac surgery. J Thorac Cardiovasc Surg 2009;57(1):25-29.
Go to original source... - Rankin JS, Oguntolu O, Binford RS, Trochtenberg DS, Muhlbaier LH, Stratton CW. Management of immune dysfunction after adult cardiac surgery. J Thorac Cardiovasc Surg 2011;142:575580.
Go to original source... - Werdan K, Gunter P, Muller-Werdan U, Enriquez MM, Schmitt DV, Mohr FW, Neeser G, Schöndube F, Schäfers HJ, Haverich A, Fraunberger P, Andersson J, Kreuzer E, Thijs LG. Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome - The ESSICS study. Crit Care Med 2008;36(3):716723.
Go to original source... - Papageorgiou AC, Acharya KR. Microbial superantigens: from structure to function. Trends Microbiol 2000;8:369-375.
Go to original source... - McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Ann Rev Microbiol 2001;55:77-104.
Go to original source... - Buda S, Riefolo A, Biscione R, Goretti E, Cattabriga I, Grillone G, Bacchi-Reggiani L, Pacini D. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery. J Cardiothorac Vasc Anesth 2005;19(4):440-445.
Go to original source... - Friedrich I, Silber RE, Bauman B, Fischer C, Holzheimer RG. IgMenriched immunoglobulin preperation for immunoprophylaxis in cardiac surgery. Eur J Med Res 2002;177(12):544-549.
- Kress HG, Scheidewig C, Schmidt H, Silber R. Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery. Crit Care Med 1999;27(7):12811287.
Go to original source... - Cines DB, Rauova L, Arepally G, Reilly MP, McKenzie SE, Sachais BS, Poncz M. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly. J Clin Apher 2007;22(1):31-36.
Go to original source...

